LoginRegister
    Producers of anti-venom, anti-toxin drugs respond to PETA PIL in Delhi High CourtProducers of anti-venom, anti-toxin drugs respond to PETA PIL in Delhi High Court
    FIRST: Lupin launches Adhero, smart device to support treatment of respiratory disease in IndiaFIRST: Lupin launches Adhero, smart device to support treatment of respiratory disease in India
    AstraZeneca leukemia drug Calquence gets USFDA okayAstraZeneca leukemia drug Calquence gets USFDA okay
    CNS Pharma acquires worldwide rights for brain cancer drug Berubicin from Houston PharmaCNS Pharma acquires worldwide rights for brain cancer drug Berubicin from Houston Pharma
    GE Healthcare gets USFDA clearance for deep learning-based CT image reconstruction technologyGE Healthcare gets USFDA clearance for deep learning-based CT image reconstruction technology
    Bristol Myers Opdivo-Yervoy combo misses main goal in late-stage skin cancer trialBristol Myers Opdivo-Yervoy combo misses main goal in late-stage skin cancer trial
    Pharmacist arrested for selling Tydol Tablets in bulk sans prescriptionPharmacist arrested for selling Tydol Tablets in bulk sans prescription
    Pharma Research being promoted by ICMR, others; Minister apprises parliament of initiativesPharma Research being promoted by ICMR, others; Minister apprises parliament of initiatives
    Lupin unveils generic version of Sun Pharma Westcort Cream to treat skin conditionsLupin unveils generic version of Sun Pharma Westcort Cream to treat skin conditions
    Alembic Pharma gets USFDA nod for generic version of Jadenu, Exjade tablet to treat chronic iron overloadAlembic Pharma gets USFDA nod for generic version of Jadenu, Exjade tablet to treat chronic iron...
    Johnson and Johnson found negligent in landmark vaginal mesh lawsuit in AustraliaJohnson and Johnson found negligent in landmark vaginal mesh lawsuit in Australia
    Bayer, WHO collaborate to combat taeniasis, neurocystercosisBayer, WHO collaborate to combat taeniasis, neurocystercosis
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X